BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22469782)

  • 1. TET2 is essential for survival and hematopoietic stem cell homeostasis.
    Shide K; Kameda T; Shimoda H; Yamaji T; Abe H; Kamiunten A; Sekine M; Hidaka T; Katayose K; Kubuki Y; Yamamoto S; Miike T; Iwakiri H; Hasuike S; Nagata K; Marutsuka K; Iwama A; Matsuda T; Kitanaka A; Shimoda K
    Leukemia; 2012 Oct; 26(10):2216-23. PubMed ID: 22469782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Functional analysis of TET2 using a knockdown mouse model].
    Shide K; Kameda T; Shimoda K
    Rinsho Ketsueki; 2015 Jun; 56(6):657-65. PubMed ID: 26256876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice.
    Ko M; Bandukwala HS; An J; Lamperti ED; Thompson EC; Hastie R; Tsangaratou A; Rajewsky K; Koralov SB; Rao A
    Proc Natl Acad Sci U S A; 2011 Aug; 108(35):14566-71. PubMed ID: 21873190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tet2 disruption leads to enhanced self-renewal and altered differentiation of fetal liver hematopoietic stem cells.
    Kunimoto H; Fukuchi Y; Sakurai M; Sadahira K; Ikeda Y; Okamoto S; Nakajima H
    Sci Rep; 2012; 2():273. PubMed ID: 22355785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies.
    Li Z; Cai X; Cai CL; Wang J; Zhang W; Petersen BE; Yang FC; Xu M
    Blood; 2011 Oct; 118(17):4509-18. PubMed ID: 21803851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TET2 as an epigenetic master regulator for normal and malignant hematopoiesis.
    Nakajima H; Kunimoto H
    Cancer Sci; 2014 Sep; 105(9):1093-9. PubMed ID: 25040794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors.
    Pronier E; Almire C; Mokrani H; Vasanthakumar A; Simon A; da Costa Reis Monte Mor B; Massé A; Le Couédic JP; Pendino F; Carbonne B; Larghero J; Ravanat JL; Casadevall N; Bernard OA; Droin N; Solary E; Godley LA; Vainchenker W; Plo I; Delhommeau F
    Blood; 2011 Sep; 118(9):2551-5. PubMed ID: 21734233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.
    Moran-Crusio K; Reavie L; Shih A; Abdel-Wahab O; Ndiaye-Lobry D; Lobry C; Figueroa ME; Vasanthakumar A; Patel J; Zhao X; Perna F; Pandey S; Madzo J; Song C; Dai Q; He C; Ibrahim S; Beran M; Zavadil J; Nimer SD; Melnick A; Godley LA; Aifantis I; Levine RL
    Cancer Cell; 2011 Jul; 20(1):11-24. PubMed ID: 21723200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent Effects of Dnmt3a and Tet2 Mutations on Hematopoietic Progenitor Cell Fitness.
    Ostrander EL; Kramer AC; Mallaney C; Celik H; Koh WK; Fairchild J; Haussler E; Zhang CRC; Challen GA
    Stem Cell Reports; 2020 Apr; 14(4):551-560. PubMed ID: 32220332
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Kunimoto H; McKenney AS; Meydan C; Shank K; Nazir A; Rapaport F; Durham B; Garrett-Bakelman FE; Pronier E; Shih AH; Melnick A; Chaudhuri J; Levine RL
    Blood; 2017 Mar; 129(13):1779-1790. PubMed ID: 28077417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-catalytic Roles of Tet2 Are Essential to Regulate Hematopoietic Stem and Progenitor Cell Homeostasis.
    Ito K; Lee J; Chrysanthou S; Zhao Y; Josephs K; Sato H; Teruya-Feldstein J; Zheng D; Dawlaty MM; Ito K
    Cell Rep; 2019 Sep; 28(10):2480-2490.e4. PubMed ID: 31484061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of TET2 in human hematopoietic stem cells alters the development and function of neutrophils.
    Huerga Encabo H; Aramburu IV; Garcia-Albornoz M; Piganeau M; Wood H; Song A; Ferrelli A; Sharma A; Minutti CM; Domart MC; Papazoglou D; Gurashi K; Llorian Sopena M; Goldstone R; Fallesen T; Wang Q; Ariza-McNaughton L; Wiseman DH; Batta K; Gupta R; Papayannopoulos V; Bonnet D
    Cell Stem Cell; 2023 Jun; 30(6):781-799.e9. PubMed ID: 37267914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TET2 deficiency inhibits mesoderm and hematopoietic differentiation in human embryonic stem cells.
    Langlois T; da Costa Reis Monte-Mor B; Lenglet G; Droin N; Marty C; Le Couédic JP; Almire C; Auger N; Mercher T; Delhommeau F; Christensen J; Helin K; Debili N; Fuks F; Bernard OA; Solary E; Vainchenker W; Plo I
    Stem Cells; 2014 Aug; 32(8):2084-97. PubMed ID: 24723429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease.
    Sano S; Oshima K; Wang Y; Katanasaka Y; Sano M; Walsh K
    Circ Res; 2018 Jul; 123(3):335-341. PubMed ID: 29728415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physioxia-induced downregulation of Tet2 in hematopoietic stem cells contributes to enhanced self-renewal.
    Aljoufi A; Zhang C; Ropa J; Chang W; Palam LR; Cooper S; Ramdas B; Capitano ML; Broxmeyer HE; Kapur R
    Blood; 2022 Sep; 140(11):1263-1277. PubMed ID: 35772013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of TET2 mutations in myeloproliferative neoplasms.
    Pronier E; Delhommeau F
    Curr Hematol Malig Rep; 2012 Mar; 7(1):57-64. PubMed ID: 22200996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic N-Ras and Tet2 haploinsufficiency collaborate to dysregulate hematopoietic stem and progenitor cells.
    Jin X; Qin T; Zhao M; Bailey N; Liu L; Yang K; Ng V; Higashimoto T; Coolon R; Ney G; Figueroa ME; Li Q
    Blood Adv; 2018 Jun; 2(11):1259-1271. PubMed ID: 29866713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis.
    Quivoron C; Couronné L; Della Valle V; Lopez CK; Plo I; Wagner-Ballon O; Do Cruzeiro M; Delhommeau F; Arnulf B; Stern MH; Godley L; Opolon P; Tilly H; Solary E; Duffourd Y; Dessen P; Merle-Beral H; Nguyen-Khac F; Fontenay M; Vainchenker W; Bastard C; Mercher T; Bernard OA
    Cancer Cell; 2011 Jul; 20(1):25-38. PubMed ID: 21723201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation.
    Song SJ; Ito K; Ala U; Kats L; Webster K; Sun SM; Jongen-Lavrencic M; Manova-Todorova K; Teruya-Feldstein J; Avigan DE; Delwel R; Pandolfi PP
    Cell Stem Cell; 2013 Jul; 13(1):87-101. PubMed ID: 23827711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tracking hematopoietic precursor division ex vivo in real time.
    Wang Y; Tian H; Cai W; Lian Z; Bhavanasi D; Wu C; Sato T; Kurokawa M; Wu D; Fu L; Wang H; Shen H; Liang D; Huang J
    Stem Cell Res Ther; 2018 Jan; 9(1):16. PubMed ID: 29361987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.